SEC 13F Intelligence

Endurant Capital Management LP / PTCT

Endurant Capital Management LP’s Ptc Therapeutics Inc Position

Does Endurant Capital Management LP own Ptc Therapeutics Inc (PTCT)? Not currently — the last reported position was 53.2K shares worth $3M in Q1 2023; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$3M
Q1 2023
Shares
53.2K
% of Portfolio
+1.32%
Quarters Held
4
position exited

Position History PTCT

Reported value by quarter
Q1 ’19: $636,000Q1 ’19Q2 ’20: $998,000Q2 ’20Q4 ’22: $682,709Q4 ’22Q1 ’23: $3MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202353.2K$3M+1.32%
Q4 202217.9K$682,709+0.28%
Q2 202019.7K$998,000+0.05%
Q1 201916.9K$636,000+0.25%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of PTCT.